Quad leaders express commitment to 'free, open' Indo-Pacific region in joint op-ed

-

In a rare move, the four leaders of the Quad grouping wrote a joint opinion piece for the Washington Post on Sunday, in which they shared their vision for an Indo-Pacific region that is “free, open, resilient and inclusive”.

The article comes two days after the first virtual summit of the Quad leaders was held. It has been co-authored by India's Prime Minister Narendra Modi, US President Joe Biden, Australian prime minister Scott Morrison and Japanese prime minister Yoshihide Suga.

In the opinion piece, the four leaders wrote, "We are striving to ensure that the Indo-Pacific is accessible and dynamic, governed by international law and bedrock principles such as freedom of navigation and peaceful resolution of disputes, and that all countries are able to make their own political choices, free from coercion. In recent years, that vision has increasingly been tested. Those trials have only strengthened our resolve to reckon with the most urgent of global challenges together."

The article noted that the governments of all four countries have worked closely for years. “On Friday, for the first time in 'Quad' history, we convened as leaders to advance meaningful cooperation at the highest level."

On efforts to combat the COVID-19 pandemic, the article wrote, "Together, we pledge to expand and accelerate production in India of safe, accessible and effective vaccines. We will partner at each stage to ensure that vaccines are administered throughout the Indo-Pacific region into 2022. We will combine our scientific ingenuity, financing, formidable productive capacity and long history of global-health partnership to surge the supply of life-saving vaccines, in close collaboration with multilateral organizations including the World Health Organization and Covax Facility."

On Friday, the Quad countries finalised a landmark initiative under which huge investments will be made in India to create additional production capacities to roll out a billion coronavirus vaccine doses by 2022. These vaccines are expected to be exported to the Indo-Pacific region, seen as a significant step to counter China's expanding vaccine diplomacy.

 



from Firstpost India Latest News https://ift.tt/3bKf1Cn
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more